Zoetis to Buy Neogen’s Animal Genomics Business for $160 Million

Reuters03-02
Zoetis to Buy Neogen’s Animal Genomics Business for $160 Million

Zoetis has agreed to buy Neogen’s animal genomics business for $160 million, subject to customary closing adjustments. Neogen’s genomics unit serves customers in more than 120 countries through five labs across the U.S., Brazil, Australia, China and the U.K., plus an office in Canada. Zoetis said it expects to complete the acquisition in the second half of 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260227496705) on March 02, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment